![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Monday, February 08, 2021 10:21:01 AM
Reading, studying and analyzing what we have learned about the current DCVax-L phase 3 trial for GBM patients, ie, the blinded, blended data published on
https://translational-medicine.biomedcentral.com/articles/10.1186/s12967-018-1507-6
and subsequent uptrending updates by Drs LL, Bosch;
the history, status and outcomes of the current standard of care, which indicates there has been almost no change in extending patients' survival both in terms of median or long term survival;
All previous phase 3 trials for GBM, and their respective results, the reasons why they all failed; and
Though despised by the majority of oncologists taking care of their GBM patients for its unclear MOA, difficult to use and added burden for already great hardship of their patients, the FDA approved Optune device has panned out quite well, illustrating the huge unmet demand. And if NWBIO updated its long-term survival data, Novocure would mysteriously come out with some cherry-picking if not outright faked data trying to have a match. All in all, if DCVax-L is approved its market cap shall double, triple the Novocure's which is currently at $19 billion.
It's pretty much certain DCVax-L trial will be significant in meeting its primary endpoint.
WE are siting at a price range of $1.5 ~ $1.7 for quite a time for a market cap of about $1.3 billion.
Some long term holders are trimming fat becoming lighter if not completely out of the game, new comers are mostly bashing (of course they want to initiate a position at a price as low as possible), and from time to time a tiny fraction of warrants gets dumped onto market. We are at a point now even nobody bothers to report their communications with DI or Les. The darkness seems to be upon us. How this situation can last.
I added about 100,000 shares in the last two weeks bringing my average up a bit
Good luck to you and all long
Recent NWBO News
- Biophma Announces Exclusive In License for Dendritic Cell Technology, Sending Shares Higher • AllPennyStocks.com • 06/17/2024 04:40:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/04/2024 09:11:16 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 06/03/2024 09:22:55 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 05/22/2024 08:13:36 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/10/2024 09:04:57 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/01/2024 10:04:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/02/2023 01:31:35 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/16/2023 10:11:54 PM
- Epazz, Inc. (OTC Pink: EPAZ) ZenaDrone Demonstration to Defense Departments of UAE and Saudi Arabia • InvestorsHub NewsWire • 11/15/2023 12:19:31 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 09:30:39 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 • InvestorsHub NewsWire • 11/09/2023 01:00:34 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 Extreme Weather Demo • InvestorsHub NewsWire • 11/07/2023 12:29:43 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/09/2023 08:36:14 PM
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM